Curia Global
Philip Macnabb joined Curia in 2023 as Chief Executive Officer. He leads the company in the pursuit of its mission to improve patients’ lives, applying end-to-end capabilities and deep scientific expertise to advance customers from idea to impact.
Phil brought more than 20 years of private-equity leadership experience to Curia, with the previous 10 years spent in the healthcare sector. Most recently, he served as Chief Executive Officer at Epselon Global, a company that he co-founded. In addition to his healthcare experience, he has held senior positions in technology, distribution, and consumer products segments. Phil has a track record of focusing companies on their core value proposition, enhancing the customer experience and building organizations with real and sustaining value.
Phil earned an MBA from the University of Chicago, and a BS in Business Administration from Purdue University.
This person is not in any offices
Curia Global
6 followers
With locations in North America, Europe and Asia, Curia’s team combines scientific expertise and market-leading technology to provide a complete suite of solutions in discovery, drug substance development, drug product formulation and process development, drug substance manufacturing, drug product manufacturing, and lab testing services.